Call Us + 33 1 84 88 31 00

Article R5121-84 of the French Public Health Code

Classification as a hospital prescription-only medicinal product may only take place if the restrictions placed on the prescription of the medicinal product are justified by the need to carry out the diagnosis and monitoring of the diseases for the treatment of which the medicinal product is normally used in establishments with suitable facilities, or by its pharmacological characteristics, its degree of innovation, or another public health reason.

Read More »

Article R5121-85 of the French Public Health Code

Classification in the category of medicinal products subject to hospital prescription means that the medicinal product may only be prescribed : 1° To a doctor, dental surgeon or midwife who meets the conditions laid down in Book I of Part IV of this Code, as well as in I of Article 60 of Law no. 99-641 of 27 July 1999 creating universal health cover, and who is practising in a…

Read More »

Article R5121-86 of the French Public Health Code

The marketing authorisation, the early access authorisation under 1° of II of article L. 5121-12 or the compassionate access authorisation under II of article L. 5121-12-1 or the compassionate prescription framework under III of article L. 5121-12-1 or the import authorisation for the medicinal product may reserve its prescription to the doctors mentioned in article R. 5121-85 who hold a qualification recognised under the conditions set out in article R….

Read More »

Article R5121-87 of the French Public Health Code

Classification in the category of medicinal products for initial prescription in hospitals may only take place if the restrictions placed on the prescription of the medicinal product are justified by the need to carry out the diagnosis of the diseases for the treatment of which the medicinal product is normally used in establishments with suitable facilities.

Read More »

Article R5121-88 of the French Public Health Code

Classification in the category of medicinal products subject to initial hospital prescription has the following effects: 1° The initial prescription of the medicinal product is reserved : a) To a doctor, dental surgeon or midwife who meets the conditions laid down in Book I of Part IV of this Code, as well as in I of article 60 of law no. 99-641 of 27 July 1999 creating universal health cover…

Read More »

Article R5121-89 of the French Public Health Code

The marketing authorisation, the early access authorisation under 1° of II of article L. 5121-12 or the compassionate access authorisation under II of article L. 5121-12-1 or the compassionate prescription framework under III of article L. 5121-12-1 or the import authorisation for the medicinal product may reserve its prescription to the doctors mentioned in article R. 5121-88 who hold a qualification recognised under the conditions set out in article R….

Read More »

Article R5121-90 of the French Public Health Code

A medicinal product may only be classified as a prescription-only medicine if the restrictions on prescribing are justified by the constraints involved in implementing the treatment, having regard to the specific nature of the pathology and the pharmacological characteristics of the medicinal product, its degree of innovation, or another public health reason.

Read More »

Article R5121-91 of the French Public Health Code

Classification in the category of medicinal products for which prescription is reserved for certain specialist doctors has the following effects: 1° The prescription or initial prescription of the medicinal product is reserved for doctors who have been awarded a specialist qualification under the conditions set out in decree no. 2004-252 of 19 March 2004 relating to the conditions under which doctors of medicine may obtain a specialist qualification; 2° In…

Read More »

Article R5121-92 of the French Public Health Code

The marketing authorisation, the early access authorisation under 1° of II of article L. 5121-12 or the compassionate access authorisation under II of article L. 5121-12-1 or the compassionate prescription framework under III of article L. 5121-12-1 or the import authorisation for the medicinal product may, depending on its characteristics, set a time limit after which the initial prescription lapses and may no longer be renewed by persons other than…

Read More »

Contact a French lawyer now

Contact a French Business Lawyer

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call us at +33 (0) 1 84 88 31 00 or send us an email.

Useful links

You have a question in French Business Law?

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call +33 (0) 1 84 88 31 00 or send us an email.

All information exchanged through this website will be communicated to lawyers registered with a French Bar and will remain confidential.